This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): ABX464
Description: ABX464 is a novel, small molecule inhibiting the biogenesis of viral RNA required for the replication of the HIV virus. In pre-clinical reference models of HIV, ABX464 was able to induce a substantial reduction in viral load that persists for weeks after treatment arrest.
Additional information available to subscribers only: